Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2116
Revised: January 13, 2004
Accepted: February 1, 2004
Published online: July 15, 2004
AIM: To investigate the association between curative effects of interferon-α and partial human leucocyte antigen (HLA) II alleles in chronic viral hepatitis B.
METHODS: Sixty patients with chronic viral hepatitis B in Shanghai were treated with a standard course of treatment with interferon-α for 6 mo. HLA-DRB1, -DQA1, and -DQB1 alleles were detected by polymerase chain reaction-sequence specific primer (PCR-SSP) method.
RESULTS: Frequencies of HLA-DRB1*04 (P < 0.025) and HLA-DQA1*0303 (P < 0.01) in non-responders were significantly higher than those in partial and complete responders. Frequencies of HLA-DQA1*0505 (P < 0.025) and HLA-DQB1*0301 (P < 0.005) in partial and complete responders were significantly higher than those in non-responders.
CONCLUSION: Non-response to interferon-α therapy is positively correlated with HLA-DRB1*04 and HLA-DQA1*0303, and negatively correlated with HLA-DQA1*0505 and -DQB1*0301 in patient with chronic viral hepatitis B. HLA II genes of the identification alleles provide a method for evaluating outcome of interferon-α treatment.